Table of Contents Table of Contents
Previous Page  881 / 1096 Next Page
Information
Show Menu
Previous Page 881 / 1096 Next Page
Page Background

S865

ESTRO 36

_______________________________________________________________________________________________

larynx (6), paranasal sinus (4) and two unknown primary

cases. Half of the cohort had been diagnosed with ORN of

the mandible within a median follow-up time of 3.2 years

(range 1.3-5.3) from the end of RT. The toxicity endpoint

considered included ORN complication of any grading. The

other 40 patients were control cases (no ORN observed)

prospectively matched according to primary site and

treatment option (PORT or primary RT and chemotherapy

type).

For given volume v

j

and dose d

i

levels, the numerical

fraction in a cell of an ACI is composed of the number of

patients (denominator) and the number of patients with

ORN (numerator) that have a mandible percentage volume

between v

j

and v

j+1

exposed to a dose level between d

i

and

d

i+1

. Atlases were created for sub-sets of the entire cohort

to investigate the effects of pre-RT surgery,

chemotherapy, smoking or dental extractions. These risk

factors were also tested with univariate statistical

analysis. Dosimetric variables including d

max

and d

mean

were

tested with ROC analysis.

Results

A dosimetric correlation with ORN incidence was observed

in cases where treatment modality was primary RT (as

opposed to post-operative RT). An increased ORN

incidence was observed towards the large percentage

volume and high doses region of the ACI, where a large

percentage of the mandible volume had received doses of

above 40Gy as well as smaller volume percentages

receiving doses above 64Gy. A similar incidence pattern

was observed for the ACI that included smoking patients

only. The ACI for the sub-set of patients that had

undergone dental extractions pre- or post-RT also showed

a very similar incidence pattern; however, this sub-set

included very few cases.

Conclusion

The ACI analysis carried out so far has shown a dose

response in patients who received primary RT, patients

who smoked at the time of diagnosis and patients who had

dental extractions. The limited number of cases did not

allow for any conclusive statistical significance of the

logistic regression and ROC analysis results. This pilot

study will be expanded to include cases from other centres

to increase the cohort size.

EP-1604 Ion induced complex DNA damage: In silico

modelling of damage and repair using Geant4-DNA.

J.W. Warmenhoven

1

, N.T. Henthorn

1

, M. Sotiropoulos

1

,

R.I. Mackay

2

, K.J. Kirkby

1,3

, M.J. Merchant

1,3

1

University of Manchester, Division of Molecular and

Clinical Cancer Sciences, Manchester, United Kingdom

2

The Christie NHS Foundation Trust, Christie Medical

Physics and Engineering, Manchester, United Kingdom

3

The Christie NHS Foundation Trust, Manchester, United

Kingdom

Purpose or Objective

This work uses Monte Carlo simulation to assess and

understand the differences in biological response to

various radiation qualities in the context of hadron

therapy. The current clinical estimator for this is Relative

Biological Effectiveness (RBE), offering a biological dose

conversion between radiation qualities. A large variability

in reported RBE measurements implies that this parameter

does not give the full picture. This variability in RBE is a

major source of uncertainty in ion therapy treatment

planning. Recently, LET based biological effect models

have been proposed, however, among those reviewed

there are uncertainties in the behaviour of key biological

parameters. We approach the problem on a mechanistic

level, linking nanoscale energy deposition to cellular

repair.

Material and Methods

We present a stochastic model to predict ion induced DNA

damage and subsequent repair. DNA damage patterns are

predicted using nanodosimetric principles applied to track

structure simulations within the Monte Carlo based

Geant4-DNA toolkit. A section of detailed DNA geometry is

irradiated to study specific DNA double strand break

structures; building up a library of break models for a

given radiation quality. These patterns are then fed into a

modified Geant4-DNA simulation where the DNA double

strand break ends are explicitly modelled within a

simplified cell nucleus. Double strand break ends then

progress along the predefined Non-Homologous End

Joining repair pathway according to stochastic, time

constant based state changes. This allows the prediction

of differences in DNA repair for a range of radiation

qualities.

Results

We show that break complexity and repair kinetics are

dependent on the particle LET and particle type, with

more complex breaks becoming more probable for higher

LET (fig 1.). Our simulations predict a greater number of

residual DSBs after 24h when higher LET particles are used

(fig 2.), which is in good agreement with the literature.

We also observe a difference in break complexity for

protons and alpha particles at the same LET due to

differences in radiation track structure.

Conclusion

Monte Carlo track structure simulation coupled to a

mechanistic DNA damage repair simulation is a useful tool

for modelling biologically relevant endpoints to cellular

radiation injury. We have modelled DSB damage and repair

with respect to several beam delivery parameters. The

complexity of the biological response caused by different

ions of the same LET was found to differ due to the